ArticleThe Journal of biological chemistry2026
A novel autopolysialylation activity of the ganglioside sialyltransferase ST8Sia5 regulates its secretion and enzyme activity.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polysialic acid (polySia) is a linear polymer of sialic acid, which usually modifies N-glycans on the neural cell adhesion molecule (NCAM) mostly in the brain and is involved in the development of brain. PolySia is also associated with several diseases, including mental disorders and cancers. ST8Sia2 and ST8Sia4 are believed to be the only polysialyltransferases that synthesize polySia on NCAM (NCAM polysialylation). These enzymes are also autopolysialylated. In this study, we first found that ST8Sia5L, a ganglioside-specific sialyltransferase, has an activity to synthesize polysialic acid on ST8Sia5 itself, but does not exhibit the NCAM polysialylation activity. Notably, in silico and biochemical analyses revealed that ST8Sia5L contains a new polysialic acid-trapping motif (PSTM) that is essential for polySia elongation, instead of the conventional polysialyltransferase domain (PSTD) found in ST8Sia2 and ST8Sia4. We also found that autopolysialylated ST8Sia5L is secreted from the cells. To identify the autopolysialylation sites involved in secretion, we performed N-glycosylation site disruption experiments, and found that N92 and N277 in the five N-glycosylation sites are important for this phenomenon. Furthermore, the inhibitor experiments showed that certain metalloprotease(s), but not exosomal pathways, are involved in the secretion. Notably, the secreted autopolysialylated enzyme showed no ganglioside-sialylation activity; however, the activity was recovered when polySia was removed by sialidase treatment. Overall, we show that autopolysialylation of ST8Sia5L regulates both its secretion and the conventional sialyltransferase activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.